美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72162-2558-1	72162-2558	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20251104	N/A	ANDA	ANDA203820	Bryant Ranch Prepack	REPAGLINIDE	1 mg/1	100 TABLET in 1 BOTTLE (72162-2558-1)
57237-159-01	57237-159	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Rising Pharma Holdings, Inc.	REPAGLINIDE	2 mg/1	100 TABLET in 1 BOTTLE (57237-159-01)
57237-159-05	57237-159	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Rising Pharma Holdings, Inc.	REPAGLINIDE	2 mg/1	500 TABLET in 1 BOTTLE (57237-159-05)
65862-671-01	65862-671	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	1 mg/1	100 TABLET in 1 BOTTLE (65862-671-01)
65862-671-05	65862-671	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	1 mg/1	500 TABLET in 1 BOTTLE (65862-671-05)
65862-671-99	65862-671	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	1 mg/1	1000 TABLET in 1 BOTTLE (65862-671-99)
57237-157-01	57237-157	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Rising Pharma Holdings, Inc.	REPAGLINIDE	.5 mg/1	100 TABLET in 1 BOTTLE (57237-157-01)
57237-157-05	57237-157	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Rising Pharma Holdings, Inc.	REPAGLINIDE	.5 mg/1	500 TABLET in 1 BOTTLE (57237-157-05)
65862-672-01	65862-672	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	2 mg/1	100 TABLET in 1 BOTTLE (65862-672-01)
65862-672-05	65862-672	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	2 mg/1	500 TABLET in 1 BOTTLE (65862-672-05)
65862-672-99	65862-672	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	2 mg/1	1000 TABLET in 1 BOTTLE (65862-672-99)
60687-560-21	60687-560	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20200917	N/A	ANDA	ANDA203820	American Health Packaging	REPAGLINIDE	1 mg/1	30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21) / 1 TABLET in 1 BLISTER PACK (60687-560-11)
57237-158-01	57237-158	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Rising Pharma Holdings, Inc.	REPAGLINIDE	1 mg/1	100 TABLET in 1 BOTTLE (57237-158-01)
57237-158-05	57237-158	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Rising Pharma Holdings, Inc.	REPAGLINIDE	1 mg/1	500 TABLET in 1 BOTTLE (57237-158-05)
65862-670-01	65862-670	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	.5 mg/1	100 TABLET in 1 BOTTLE (65862-670-01)
65862-670-05	65862-670	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	.5 mg/1	500 TABLET in 1 BOTTLE (65862-670-05)
65862-670-99	65862-670	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20140122	N/A	ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	.5 mg/1	1000 TABLET in 1 BOTTLE (65862-670-99)
63629-4866-1	63629-4866	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20250116	N/A	ANDA	ANDA203820	Bryant Ranch Prepack	REPAGLINIDE	.5 mg/1	30 TABLET in 1 BOTTLE (63629-4866-1)
63629-4866-2	63629-4866	HUMAN PRESCRIPTION DRUG	Repaglinide	Repaglinide	TABLET	ORAL	20250116	N/A	ANDA	ANDA203820	Bryant Ranch Prepack	REPAGLINIDE	.5 mg/1	90 TABLET in 1 BOTTLE (63629-4866-2)